Home/Filings/4/0001209191-21-045052
4//SEC Filing

MEDEL ROGER MD 4

Accession 0001209191-21-045052

CIK 0000893949other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 5:00 PM ET

Size

5.2 KB

Accession

0001209191-21-045052

Insider Transaction Report

Form 4
Period: 2021-07-01
MEDEL ROGER MD
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2021-07-01$30.31/sh100,000$3,031,0001,222,542 total
Footnotes (2)
  • [F1]Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 13, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in eighty-seven (87) separate transactions with prices ranging from $30.08 to $30.53 for an average weighted sale price of $30.31. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

MEDNAX, INC.

CIK 0000893949

Entity typeother

Related Parties

1
  • filerCIK 0001093125

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:00 PM ET
Size
5.2 KB